Literature DB >> 352251

Pharmacokinetics of cephalosporin antibiotics.

J M Brogard, F Comte, M Pinget.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352251     DOI: 10.1159/000401060

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


× No keyword cloud information.
  13 in total

1.  Pharmacokinetics of cefotaxime.

Authors:  K P Fu; P Aswapokee; I Ho; C Matthijssen; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.

Authors:  K S Israel; H R Black; G L Brier; J D Wolny; K A DeSante
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

3.  Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.

Authors:  S Srinivasan; K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Pharmacology of ceftizoxime compared with that of cefamandole.

Authors:  H C Neu; S Srinivasan
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

5.  Multiple-dose pharmacokinetics of ceftazidime in cancer patients.

Authors:  I Garcia; V Fainstein; R G Smith; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

6.  Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.

Authors:  S Srinivasan; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

Review 7.  Pharmacokinetic properties of the cephalosporins.

Authors:  T Bergan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.

Authors:  M Nadai; T Hasegawa; K Kato; L Wang; T Nabeshima; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics.

Authors:  Masanori Nakakariya; Taiki Shimada; Masanori Irokawa; Hiroyuki Koibuchi; Takashi Iwanaga; Hikaru Yabuuchi; Tomoji Maeda; Ikumi Tamai
Journal:  Pharm Res       Date:  2007-09-22       Impact factor: 4.200

10.  Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.

Authors:  K Konishi; Y Ozawa
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.